InvestorsHub Logo
Followers 83
Posts 6960
Boards Moderated 0
Alias Born 01/29/2007

Re: None

Monday, 08/02/2010 1:46:34 PM

Monday, August 02, 2010 1:46:34 PM

Post# of 64411
RedChip Blog Aricle on Cobroxin http://blog.redchip.com/

found this searching Goggle on painmed investments. looks like RedChip will regularly get the story out, not just the report.

July 30th, 2010
Suffering From Arthritis Pain? Try XenaCare’s Cobra Venom
In 2002, a man named Joe de Casa was working in his Northamptonshire garden in England when an adder snake suddenly jumped out and bit him in the hand. Luckily, he survived the bite. Like many seniors, at 61, Joe had been a sufferer of severe arthritis for many years in his wrists and fingers, and in the months following the snake bite, he claimed that he experienced the only pain free days in years. “I would quite like to find another snake and invite him to bite me. I am not suggesting that it cures arthritis, but it could possibly have anti-inflammatory properties,” Mr. De Casa said. Each year, thousands of people across the globe die from poisonous snakebites. Who would have guessed that scientists and researchers would one day isolate beneficial components from otherwise deadly venom for use in medical applications? Yet eight years after Joe de Casa’s surprising discovery, scientists have developed an over-the-counter pain reliever derived from cobra venom under the brand-name Cobroxin™.

XenaCare Holdings, Inc.(OTCBB: XCHO), a company specializing in the branding, marketing and retail distribution of consumer healthcare products, recently launched a large-scale advertising campaign for Cobroxin, the company’s primary product. Cobroxin is the first OTC pain reliever proven to treat moderate to severe chronic pain, any discomfort severe enough to interfere with work and sleep. Many other drugs in this category, like Vicodin and Percocet, require prescriptions. Cobroxin works by a different mechanism than that of the usual over-the-counter pain-relieving drugs such as Tylenol or Advil, or opioids, such as Vicodin, OxyContin, or morphine. XenaCare is positioning Cobroxin as a unique alternative for individuals who cannot tolerate or are not getting relief from OTC medicines and who would like to avoid the side effects of opioids. A few of the characteristics that make Cobroxin superior to opiate drugs are that it is all natural, non-addictive, non-narcotic, and long-lasting.

The drug is currently available as an oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia. It is also available as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

XenaCare has reached sales agreements with a number of drug store and food market chains, including such major companies as Walgreens, CVS, Winn-Dixie, Publix, RiteAid, Duane Reade, and Meijer. The company expects widening distribution and heavier advertising to accelerate growth in the second half of 2010.

Cobra venom may also be effective as an anti-aging agent, studies show, since it appears to inhibit collagen breakdown. With more research somebody could possibly make a lot of money off this idea!

Disclosure: The subject security is a client of RedChip Companies, Inc. RedChip Companies, Inc., employees and affiliates may have positions and affect transactions in the securities or options of the issuers mentioned herein. For full financial disclosures for all RedChip clients, please visit http://www.redchip.com/disclosures.asp?src=rcv.